ASPREE

Clinical trial (ASPirin in Reducing Events in the Elderly) assessing low-dose aspirin for primary prevention in healthy older people, showing a non-significant cardiovascular benefit, a higher risk of major haemorrhage and excess all-cause mortality, mainly attributed to cancer.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.